A MAHA Summit on 11/19 will hear from vice president JD Vance, HHS secretary Robert F. Kennedy, Jr., and FDA commissioner Marty Makary, among many oth...
A biotechnology company specializing in adult-derived stem cells urges FDA to relax federal regulation of some regenerative therapies.
Cumberland Pharmaceuticals asks FDA to ensure that labeling for generic Acetadote products includes information from the innovator labeling about a tw...
FDA joins the United States Pharmacopeia and the Association for Accessible Medicines next month for a public workshop focused on how compendial stand...
Orrick attorneys say discussions at an FDA Digital Health Advisory Committee meeting indicate the agency intends to adopt oversight of generative arti...
FDA approves Promegas OncoMate MSI Dx Analysis System as a companion diagnostic for identifying endometrial carcinoma patients who may benefit from tr...
FDA warns New Zealands Miers Laboratories about repeat CGMP violations in its manufacturing of finished drugs.
Neurocrine Biosciences reports that its Phase 2 study of NBI-1070770, an investigational NMDA receptor modulator for major depressive disorder, failed...
